These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Qualitative analysis of anatomopathological changes of gastric mucosa due to long term therapy with proton pump inhibitors: experimental studies x clinical studies. de Souza IK; da Silva AL; de Araújo A; Santos FC; Mendonça BP Arq Bras Cir Dig; 2013; 26(4):328-34. PubMed ID: 24510044 [TBL] [Abstract][Full Text] [Related]
24. Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy. Dubois RW; Melmed GY; Henning JM; Laine L Aliment Pharmacol Ther; 2004 Jan; 19(2):197-208. PubMed ID: 14723611 [TBL] [Abstract][Full Text] [Related]
25. Dosing of proton pump inhibitors in a private hospital in Hong Kong. Mui AC; Fan TC Hong Kong Med J; 2007 Dec; 13(6):430-5. PubMed ID: 18057430 [TBL] [Abstract][Full Text] [Related]
27. Techniques for retrievability and for registering screw access holes in cement-retained implant-supported prostheses: A scoping review of the literature. Malpartida-Carrillo V; Tinedo-Lopez PL; Ortiz-Culca F; Guerrero ME; Amaya-Pajares SP J Prosthet Dent; 2020 Mar; 123(3):427-433. PubMed ID: 31307803 [TBL] [Abstract][Full Text] [Related]
28. Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES. Li DK; Yan P; Abou-Samra AB; Chung RT; Butt AA Aliment Pharmacol Ther; 2018 Jan; 47(2):246-258. PubMed ID: 29105111 [TBL] [Abstract][Full Text] [Related]
29. Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors. Janett S; Camozzi P; Peeters GG; Lava SA; Simonetti GD; Goeggel Simonetti B; Bianchetti MG; Milani GP Gastroenterol Res Pract; 2015; 2015():951768. PubMed ID: 26064102 [TBL] [Abstract][Full Text] [Related]
30. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database. Bashford JN; Norwood J; Chapman SR BMJ; 1998 Aug; 317(7156):452-6. PubMed ID: 9703528 [TBL] [Abstract][Full Text] [Related]
31. Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors. Hunfeld NG; Geus WP; Kuipers EJ Aliment Pharmacol Ther; 2007 Jan; 25(1):39-46. PubMed ID: 17229219 [TBL] [Abstract][Full Text] [Related]
32. An overview of proton pump inhibitors. Der G Gastroenterol Nurs; 2003; 26(5):182-90. PubMed ID: 14603076 [TBL] [Abstract][Full Text] [Related]
33. Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn. Dickman R; Schiff E; Holland A; Wright C; Sarela SR; Han B; Fass R Aliment Pharmacol Ther; 2007 Nov; 26(10):1333-44. PubMed ID: 17875198 [TBL] [Abstract][Full Text] [Related]
34. Cost analysis of endoscopic antireflux procedures: endoluminal plication vs. radiofrequency coagulation vs. treatment with a proton pump inhibitor. Harewood GC; Gostout CJ Gastrointest Endosc; 2003 Oct; 58(4):493-9. PubMed ID: 14520279 [TBL] [Abstract][Full Text] [Related]
35. Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care. Martin RM; Lim AG; Kerry SM; Hilton SR Aliment Pharmacol Ther; 1998 Aug; 12(8):797-805. PubMed ID: 9726394 [TBL] [Abstract][Full Text] [Related]
36. Systematic review: Proton pump inhibitor-associated acute interstitial nephritis. Sierra F; Suarez M; Rey M; Vela MF Aliment Pharmacol Ther; 2007 Aug; 26(4):545-53. PubMed ID: 17661758 [TBL] [Abstract][Full Text] [Related]
37. Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use. Klok RM; Postma MJ; van Hout BA; Brouwers JR Aliment Pharmacol Ther; 2003 May; 17(10):1237-45. PubMed ID: 12755837 [TBL] [Abstract][Full Text] [Related]